Last reviewed · How we verify
Bupivacaine Injectable Solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bupivacaine Injectable Solution (Bupivacaine Injectable Solution) — The Cooper Health System.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bupivacaine Injectable Solution TARGET | Bupivacaine Injectable Solution | The Cooper Health System | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bupivacaine Injectable Solution CI watch — RSS
- Bupivacaine Injectable Solution CI watch — Atom
- Bupivacaine Injectable Solution CI watch — JSON
- Bupivacaine Injectable Solution alone — RSS
Cite this brief
Drug Landscape (2026). Bupivacaine Injectable Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-injectable-solution. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab